🇺🇸 FDA
Pipeline program

HEC585

HEC585-P-03

Phase 2 small_molecule active

Quick answer

HEC585 for Idiopathic Pulmonary Fibrosis is a Phase 2 program (small_molecule) at Sunshine Biopharma with 5 ClinicalTrials.gov record(s).

Program details

Company
Sunshine Biopharma
Indication
Idiopathic Pulmonary Fibrosis
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials